Ajay J. Kirtane, M.D., associate professor of medicine at Columbia University Irving Medical Center and director of the cardiac catheterization laboratories at NewYork-Presbyterian (NYP) Hospital, shares the findings of the late-breaking EVOLVE Short DAPT study presented as a late-breaking trial at the 2019 Transcatheter Cardiovascular Therapeutics (TCT) meeting.
October 11, 2019
News | Drug-Eluting Balloons
October 10, 2019 — An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no ...
October 10, 2019
News | Hypertension
October 10. 2019 — Late-breaking results from its MODERATO II double-blind, randomized study of BackBeat Cardiac ...
October 10, 2019Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional ...
October 10, 2019
Fujifilm Medical Systems U.S.A. Inc. recently launched Synapse Cardiology PACS 5.6.1, the company’s next-generation server-side rendering solution to help streamline image review and reporting across cardiovascular modalities. This technology is currently in clinical use at North Memorial Health, a Minneapolis-area health system and one of the nation’s top-rated hospitals for cardiovascular care.
October 10, 2019
News | Angiography
In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-date with the most advanced systems while also keeping costs down. Providers now have a solution from Canon Medical Systems USA: the Alphenix Encore Plus Program. The program enables customers to upgrade their aging angiography systems to the latest technology while maintaining many existing parts, delivering clinical excellence, operational continuity and cost savings.
October 09, 2019Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Acutus Medical and Innovative Health announced a partnership that will offer advanced electrophysiology technology to improve patient outcomes in a cost-efficient manner. The two high profile venture-backed companies will team to offer hospital customers a comprehensive suite of EP products, including Acutus’ next-generation EP mapping and accessory products together with a growing portfolio of reprocessed single-use EP devices from a range of manufacturers.
October 09, 2019
Technology | Blood Testing
Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received clearance from the U.S. Food and Drug Administration (FDA). As one of the most researched troponin diagnostic tests, doctors in the U.S. can now utilize this proven technology to help detect heart attacks faster and more accurately than contemporary troponin tests.
October 09, 2019
Videos | Heart Valve Technology
Torsten Vahl, M.D., director of experimental and translational research, Structural Heart and Valve Center and at the ...
October 09, 2019Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Stent Grafts
Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Valiant TAAA Stent Graft System for minimally invasive repair of thoracoabdominal aortic aneurysm (TAAA). A TAAA is a complex condition causing a bulging of the aorta, which extends from the chest down into the abdomen.
October 09, 2019
News
October 9, 2019 — Medtronic is recalling the 6 French Sherpa NX Active Guide Catheter due to a risk of the outer ...
October 09, 2019
News | ACC
Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC) Annual Scientific Session. Drachman will serve as vice chair for ACC.21 and ACC.22 and transition to chair for ACC.23 and ACC.24.
October 08, 2019Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Stent Grafts
PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) trial of the company’s Torus stent graft. The novel stent graft platform is designed for the treatment of peripheral artery disease (PAD) in the superficial femoral artery (SFA). By acquiring early U.S. Food and Drug Administration (FDA) feedback through the pre-submission process, the TORUS-2 study (The PQ Bypass pivOtal IDE intra-aRterial stent graft study for occlUsive and re-Stenotic fem-pop revascularization) is the company’s second IDE approved in less than two years and is the first pivotal IDE for an SFA stent graft since Viabahn received initial premarket approval (PMA) in 2005.
October 08, 2019
American Heart Association President Robert Harrington, M.D., explains the reasons for shorter duration dual-antiplatelet therapy (DAPT) in high-risk bleeding patient
October 08, 2019
Videos | Cardiogenic Shock
William O’Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit, explains data on first 250 patients in the National Cardiogenic Shock Initiative Study (NCSI) and new escalation protocols
October 08, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now